Northwire Canada EditionMonday, July 13, 2026
Sign inSubscribe
Northwire
⌕
S 0.160 +3.2% OMI 0.315 +0.0% BMM 4.02 +5.8% CGD 0.630 +10.5% OCG 0.275 −1.8% CAMB 0.990 −1.0% HMR 0.600 −3.2% GOFL 0.025 +0.0% SIG 1.01 −1.9% SGQ 0.300 +0.0% AMCO 0.220 −12.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.390 −2.5% LIB 0.800 −12.1% SMY 0.290 +23.4% S 0.160 +3.2% OMI 0.315 +0.0% BMM 4.02 +5.8% CGD 0.630 +10.5% OCG 0.275 −1.8% CAMB 0.990 −1.0% HMR 0.600 −3.2% GOFL 0.025 +0.0% SIG 1.01 −1.9% SGQ 0.300 +0.0% AMCO 0.220 −12.0% TRS 0.055 +0.0% RRI 0.265 +0.0% GAL 0.390 −2.5% LIB 0.800 −12.1% SMY 0.290 +23.4%
Financings

Restart Life Sciences Announces Closing First Tranche of Financing

By The Northwire Desk — AI Analysis Dec 05, 2025 · 17:01 HEAL · 0.1 Restart Life Sciences Corp.
HEAL · Price

Executive Summary

  • Restart Life Sciences Corp. closed the first tranche of its non‑brokered private placement, raising CDN $500,000.
  • Issued 5,000,000 units at CDN $0.10 per unit; each unit includes one common share and one transferable warrant.
  • Proceeds will be used for health‑food trials, potential acquisitions, and general working capital.

Key Details

  • Placement Size: Gross proceeds of CDN $500,000.
  • Units Issued: 5,000,000 units at CDN $0.10 per unit.
  • Unit Composition: 1 common share + 1 transferable common‑share purchase warrant (exercise price CAD $0.10, one‑year term).
  • Finder Compensation: Cash finder’s fees of CAD $16,800 and issuance of 60,000 non‑transferable finder warrants (each for one common share at CAD $0.10, one‑year term).
  • Hold Period: All securities subject to a hold period of four months and one day, expiring April 6, 2026.
  • Use of Proceeds: Allocation toward health food trials, potential acquisitions, and general working capital.

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from Restart Life Sciences Corp.

Jun 18, 2026 · 06:01

Restart Life Advances AI-Driven E-Commerce Strategy to Scale Online Sales Growth for Holy Crap Foods

Production / Operations Jun 10, 2026 · 08:01

Restart Life Subsidiary Holy Crap Foods Marks New International Expansion Milestone with Bahamas On-Demand App Launch

Production / Operations Jun 03, 2026 · 06:01

Restart Life Sciences Taps CFO to Steer Holy Crap Foods' North American Expansion and Omnichannel Push

M&A / Property May 21, 2026 · 06:01

Restart Life Closes Financing as Revenue Growth Fails to Halt Stock Erosion

Financings May 15, 2026 · 16:00

Restart Life Sciences Advances New Product Relaunch Utilizing Acquired Intellectual Property Portfolio

Production / Operations May 13, 2026 · 06:01

Restart Life Sciences Expands U.S. Footprint via Amazon Logistics Amidst Modest Revenue Growth and Capital Dilution

Other